Literature DB >> 15550453

Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.

Christine L E Siezen1, Astrid I M van Leeuwen, Nicolien R Kram, Manon E M Luken, Henk J van Kranen, Ellen Kampman.   

Abstract

Associations between polymorphisms in genes (SNPs) involved in the arachidonic acid (AA) pathway and colorectal adenomas have been investigated in a Dutch case control study including 384 cases and 403 polyp-free controls. Twenty-one polymorphisms in seven candidate genes were studied and a potential modifying effect of fish consumption was considered. A protective effect on colorectal adenomas was found for the CT genotype of SNP H477H in PPARgamma and the GC genotype of SNP V102V in COX-2 (OR 0.63, 95% CI 0.45-0.89 and OR 0.65, 95% CI 0.46-0.92, respectively) compared with the homozygous major genotypes. An increase in adenoma risk was observed for the TC genotype of SNP c.2242T-->C in COX-2 (OR 1.47, 95% CI 1.07-2.00) compared with the TT genotype. Analysis with estimated haplotypes confirmed these associations and revealed three additional associations with COX-2, sPLA(2) and 15LOX haplotypes. Fish consumption modified the associations with COX-2 and PPARdelta genotypes. For SNP c.-789C-->T in PPARdelta the major genotype showed a decrease in adenoma risk for those in the highest tertile of fish consumption (T3), as compared with the lowest tertile (T1) (OR 0.65, 95% CI 0.41-1.02). Protective effects were also observed for SNPs V102V and c.2242T-->C in COX-2 and high fish intake. The interaction between fish consumption and c.2242T-->C was statistically significant, with an OR for the TT genotype and high fish consumption of 0.52 (95% CI 0.27-1.01) as compared with low fish intake. These results indicate that SNPs in genes involved in the AA pathway are associated with colorectal adenoma risk. Some of these associations are modified by fish consumption.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550453     DOI: 10.1093/carcin/bgh336

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  24 in total

Review 1.  Polyunsaturated fatty acid metabolism in prostate cancer.

Authors:  Isabelle M Berquin; Iris J Edwards; Steven J Kridel; Yong Q Chen
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts microRNA-mediated regulation.

Authors:  A E Moore; L E Young; D A Dixon
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

3.  Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk.

Authors:  Wei Wang; Yan Shao; Shenhua Tang; Xianyong Cheng; Haifeng Lian; Chengyong Qin
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Linkage disequilibrium and haplotype analysis of COX-2 and risk of colorectal adenoma development.

Authors:  John Kwagyan; Victor Apprey; Hassan Ashktorab
Journal:  Clin Transl Sci       Date:  2012-01-10       Impact factor: 4.689

5.  Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.

Authors:  Khouloud Chehaibi; Samir Nouira; Kacem Mahdouani; Sonia Hamdi; Mustapha Rouis; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2014-05-21       Impact factor: 3.444

Review 6.  Mechanistic aspects of COX-2 expression in colorectal neoplasia.

Authors:  Dan A Dixon; Fernando F Blanco; Annalisa Bruno; Paola Patrignani
Journal:  Recent Results Cancer Res       Date:  2013

7.  A study of prostaglandin pathway genes and interactions with current nonsteroidal anti-inflammatory drug use in colorectal adenoma.

Authors:  Todd L Edwards; Martha J Shrubsole; Qiuyin Cai; Guoliang Li; Qi Dai; Douglas K Rex; Thomas M Ulbright; Zhenming Fu; Harvey J Murff; Walter Smalley; Reid Ness; Wei Zheng
Journal:  Cancer Prev Res (Phila)       Date:  2012-05-02

8.  An association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition.

Authors:  Jason Ross; Linda Lockett; Diana Brookes; Bruce Tabor; Konsta Duesing; Michael Buckley; Trevor Lockett; Peter Molloy; Finlay Macrae; Graeme Young; Ignacio Blanco; Gabriel Capella; Garry N Hannan
Journal:  Eur J Hum Genet       Date:  2013-03-27       Impact factor: 4.246

Review 9.  Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review.

Authors:  A P Knopperts; M Nielsen; R C Niessen; C M J Tops; B Jorritsma; J Varkevisser; J Wijnen; C L E Siezen; R C Heine-Bröring; H J van Kranen; Y J Vos; H Westers; E Kampman; R H Sijmons; F J Hes
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

Review 10.  Multi-targeted therapy of cancer by omega-3 fatty acids.

Authors:  Isabelle M Berquin; Iris J Edwards; Yong Q Chen
Journal:  Cancer Lett       Date:  2008-05-13       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.